skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Leukopenia remover assunto: Young Adult remover Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis
Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis

Zhu, Jieyun ; Ji, Pan ; Pang, Jielong ; Zhong, Zhimei ; Li, Hongyuan ; He, Cuiying ; Zhang, Jianfeng ; Zhao, Chunling

Journal of medical virology, 2020-10, Vol.92 (10), p.1902-1914 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Fang, Wenfeng ; Yang, Yunpeng ; Ma, Yuxiang ; Hong, Shaodong ; Lin, Lizhu ; He, Xiaohui ; Xiong, Jianping ; Li, Ping ; Zhao, Hongyun ; Huang, Yan ; Zhang, Yang ; Chen, Likun ; Zhou, Ningning ; Zhao, Yuanyuan ; Hou, Xue ; Yang, Qing ; Zhang, Li

The lancet oncology, 2018-10, Vol.19 (10), p.1338-1350 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

Tap, William D ; Wagner, Andrew J ; Schöffski, Patrick ; Martin-Broto, Javier ; Krarup-Hansen, Anders ; Ganjoo, Kristen N ; Yen, Chueh-Chuan ; Abdul Razak, Albiruni R ; Spira, Alexander ; Kawai, Akira ; Le Cesne, Axel ; Van Tine, Brian A ; Naito, Yoichi ; Park, Se Hoon ; Fedenko, Alexander ; Pápai, Zsuzsanna ; Soldatenkova, Victoria ; Shahir, Ashwin ; Mo, Gary ; Wright, Jennifer ; Jones, Robin L

JAMA : the journal of the American Medical Association, 2020-04, Vol.323 (13), p.1266-1276 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
4
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Zhong, Wen-Zhao ; Wang, Qun ; Mao, Wei-Min ; Xu, Song-Tao ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Yan, Hong-Hong ; Yang, Xue-Ning ; Zhou, Qing ; Wu, Yi-Long ; Wu, Yi-Long ; Wang, Qun ; Mao, Wei-Min ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Wang, Si-Yu ; Hu, Jian ; Liu, Wei ; Li, Wei ; Shi, Jian-Hua

The lancet oncology, 2018-01, Vol.19 (1), p.139-148 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Laetsch, Theodore W ; DuBois, Steven G ; Mascarenhas, Leo ; Turpin, Brian ; Federman, Noah ; Albert, Catherine M ; Nagasubramanian, Ramamoorthy ; Davis, Jessica L ; Rudzinski, Erin ; Feraco, Angela M ; Tuch, Brian B ; Ebata, Kevin T ; Reynolds, Mark ; Smith, Steven ; Cruickshank, Scott ; Cox, Michael C ; Pappo, Alberto S ; Hawkins, Douglas S

The lancet oncology, 2018-05, Vol.19 (5), p.705-714 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Bisogno, Gianni ; De Salvo, Gian Luca ; Bergeron, Christophe ; Gallego Melcón, Soledad ; Merks, Johannes H ; Kelsey, Anna ; Martelli, Helene ; Minard-Colin, Veronique ; Orbach, Daniel ; Glosli, Heidi ; Chisholm, Julia ; Casanova, Michela ; Zanetti, Ilaria ; Devalck, Christine ; Ben-Arush, Myriam ; Mudry, Peter ; Ferman, Sima ; Jenney, Meriel ; Ferrari, Andrea

The lancet oncology, 2019-11, Vol.20 (11), p.1566-1575 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Borchmann, Peter ; Plütschow, Annette ; Kobe, Carsten ; Greil, Richard ; Meissner, Julia ; Topp, Max S ; Ostermann, Helmut ; Dierlamm, Judith ; Mohm, Johannes ; Thiemer, Julia ; Sökler, Martin ; Kerkhoff, Andrea ; Ahlborn, Miriam ; Halbsguth, Teresa V ; Martin, Sonja ; Keller, Ulrich ; Balabanov, Stefan ; Pabst, Thomas ; Vogelhuber, Martin ; Hüttmann, Andreas ; Wilhelm, Martin ; Zijlstra, Josée M ; Moccia, Alden ; Kuhnert, Georg ; Bröckelmann, Paul J ; von Tresckow, Bastian ; Fuchs, Michael ; Klimm, Beate ; Rosenwald, Andreas ; Eich, Hans ; Baues, Christian ; Marnitz, Simone ; Hallek, Michael ; Diehl, Volker ; Dietlein, Markus ; Engert, Andreas

The lancet oncology, 2021-02, Vol.22 (2), p.223-234 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias
Material Type:
Artigo 		Adicionar ao Meu Espaço

Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias

Gibson, Christopher J. ; Kennedy, James A. ; Nikiforow, Sarah ; Kuo, Frank C. ; Alyea, Edwin P. ; Ho, Vincent ; Ritz, Jerome ; Soiffer, Robert ; Antin, Joseph H. ; Lindsley, R.Coleman

Blood, 2017-07, Vol.130 (1), p.91-94 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Telaprevir for Retreatment of HCV Infection
Telaprevir for Retreatment of HCV Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Telaprevir for Retreatment of HCV Infection

Zeuzem, Stefan ; Andreone, Pietro ; Pol, Stanislas ; Lawitz, Eric ; Diago, Moises ; Roberts, Stuart ; Focaccia, Roberto ; Younossi, Zobair ; Foster, Graham R ; Horban, Andrzej ; Ferenci, Peter ; Nevens, Frederik ; Müllhaupt, Beat ; Pockros, Paul ; Terg, Ruben ; Shouval, Daniel ; van Hoek, Bart ; Weiland, Ola ; Van Heeswijk, Rolf ; De Meyer, Sandra ; Luo, Don ; Boogaerts, Griet ; Polo, Ramon ; Picchio, Gaston ; Beumont, Maria

The New England journal of medicine, 2011-06, Vol.364 (25), p.2417-2428 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
10
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial

Weiss, Aaron R ; Chen, Yen-Lin ; Scharschmidt, Thomas J ; Chi, Yueh-Yun ; Tian, Jing ; Black, Jennifer O ; Davis, Jessica L ; Fanburg-Smith, Julie C ; Zambrano, Eduardo ; Anderson, James ; Arens, Robin ; Binitie, Odion ; Choy, Edwin ; Davis, Justin W ; Hayes-Jordan, Andrea ; Kao, Simon C ; Kayton, Mark L ; Kessel, Sandy ; Lim, Ruth ; Meyer, William H ; Million, Lynn ; Okuno, Scott H ; Ostrenga, Andrew ; Parisi, Marguerite T ; Pryma, Daniel A ; Randall, R Lor ; Rosen, Mark A ; Schlapkohl, Mary ; Shulkin, Barry L ; Smith, Ethan A ; Sorger, Joel I ; Terezakis, Stephanie ; Hawkins, Douglas S ; Spunt, Sheri L ; Wang, Dian

The lancet oncology, 2020-08, Vol.21 (8), p.1110-1122 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (153)

Refinar Meus Resultados

Assunto 

  1. Adult  (152)
  2. Science & Technology  (150)
  3. Life Sciences & Biomedicine  (131)
  4. Middle Aged  (131)
  5. Adolescent  (106)
  6. Aged  (99)
  7. Patients  (78)
  8. Thrombocytopenia  (62)
  9. Retrospective Studies  (53)
  10. Oncology  (53)
  11. Neutropenia  (44)
  12. Chemotherapy  (39)
  13. Medicine  (39)
  14. Toxicity  (37)
  15. Treatment Outcome  (37)
  16. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2010  (6)
  2. 2010Até2012  (21)
  3. 2013Até2015  (17)
  4. 2016Até2019  (78)
  5. Após 2019  (37)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.